Pharmafile Logo

The Exhibition Hall: Past, Present and Future

May 21, 2019 | Congress, Exhibits, exhibition 

As I sit here at another pharma conference, I start to reflect on how they have changed over the years.

Back in 2004 I joined an agency that produced exhibition stands/booths for pharmaceutical clients. The beginning of the following year was my first taste of how a booth is designed and run; this was an industry I wasn’t familiar with when I joined. The stand we had built was around 400m2 and had three brands running across it. We had absolutely filled this with interactive technology. Each brand had multiple game stations and six 42” plasma screens with rolling content, all of which we had developed in-house, to educate the delegates on how that particular drug worked in a gamified way.

What I hadn’t realised was how much stuff was being used as giveaways. There were small hand-held digital video cameras, laser pointers, bags, pens, Post-it note pads — you name it, we were probably giving it away. All the games had a high score leaderboard, and if you were at the top of it at the end of the day you could collect one of the more lucrative prizes. (Before you get too excited, this was 2005, so the digital cameras had a whopping two megapixels — yes, two megapixels — which was a real game changer back then.)

Over the three days the stand was always packed. At the breaks it was hard to move from your current position. Delegates would strip you of all the pens and bags you were carrying before you had even made it out of the store room. They came in their droves to play the games, get high scores on the leaderboard for a chance to win to the main prize, and collect as much of the giveaways as they could carry or stuff into a tote bag.

Our client wasn’t the only one doing this — their competitors were all doing the same. The hall was filled with pharma companies, big and small, all trying to sell their products to the prospective customer. It was all about who could attract the most delegates with the most attractive interactive technology, and then send them on their way with as much branded merchandise as possible.

One thing I had noticed is the device companies were all pushed to the outside walls with little pop ups exhibiting their products, trying desperately to be noticed.

For the next few years, we as a company started really pushing what was possible with technology. We hacked Wii controllers Xbox cameras and-adapted PlayStation steering wheels to name but a few, all to create bespoke, mind-blowing attracts for our clients.

Fast forward to 2019. The exhibition hall, in my opinion, is a very different place. The reason is compliance.

These big pharma companies are struggling to attract delegates onto their booths. Once the games, the giveaways and the pens, once known as the doctor’s kryptonite, had been removed, there just wasn’t the draw into the hall anymore.

It seems that the only option they have left is to use large LED displays to promote their products. Yes, there are a few stands that are using VR and AR, but again they are restricted. These attracts must be educational and not a game or content that is rewarded with a prize.

A few of the big Pharma companies have decided against attending these shows as there isn’t the return on investment for them that there used to be. Some have decided to invest more money and time in the symposium and then have only a small presence in the exhibition hall.

On the flip side, the device companies have benefitted from this situation. It has allowed them to have the bigger spaces and a greater presence and at some shows, and they can still give away luxury prizes because they don’t have the same restrictions as pharma1.

So my question is, what can these pharma companies do now to entice the delegates back into the hall and onto their booths? Or are we going to see them remove the booth altogether and just run their workshops independently?

1. Association of British HealthTech Industries. Code of Ethical Business Practice, Chapter 9 A48. July 2018. Available at: http://www.abhicodeofpractice.org.uk/multimedia/New%20Folder/ABHI%20Code%20of%20Business%20Practice%20(final)%20-%20July%202018.pdf. Accessed April 2019.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters...

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters...

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters...

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters...

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters...

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...

Clinical trials explained: Why iconography matters...

Icons serve as a useful form of alternative communication. We spend a lot of time developing icons for healthcare communications. Find out how we use iconography to elevate clinical trial...

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.

Using generative AI in healthcare comms - our promise to our clients

It’s safe to say one of the hottest topics of 2023 has been ChatGPT and the launch of other Generative AI-driven applications. So, we’re sharing our promises, so that when...